⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CPIX News
Cumberland Pharmaceuticals Inc
RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation
prnewswire.com
RDHL
CPIX
RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo
prnewswire.com
RDHL
CPIX
Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis
prnewswire.com
CPIX
CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIVĀ® IN CHINA
prnewswire.com
CPIX
Form 8-K
sec.gov
CPIX
CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
prnewswire.com
CPIX
RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease
prnewswire.com
RDHL
CPIX
RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights
prnewswire.com
RDHL
CPIX
Form 8-K
sec.gov
CPIX
Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses
prnewswire.com
CPIX